Most GVHD patients should have insurance, which would be how they paid for an expensive bone marrow transplant.
Developing GVHD greatly increases the cost of post transplant care, and insurance companies should be willing to pay a lot for a cure which can greatly reduce these post transplant costs.
https://www.astctjournal.org/article/S2666-6367(23)01362-3/fulltext
banter and General Discussion, page-10077
-
- There are more pages in this discussion • 724 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
99.5¢ |
Change
-0.070(6.57%) |
Mkt cap ! $1.136B | |||
| Open | High | Low | Value | Volume |
| $1.04 | $1.04 | 99.5¢ | $3.980M | 3.944M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 8 | 56239 | 99.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.00 | 103125 | 2 |
View Market Depth
| Last trade - 16.10pm 04/09/2024 (20 minute delay) ? |
| MSB (ASX) Chart |